Dr. David A. Altman, MD

Dr. Altman practices at Midwest Center for Dermatology & Pathology in Warren, Michigan.

Dr. Altman's NPI, 1205831005, was assigned on June 17, 2005. Dr. Altman graduated from University Of Michigan Medical School in 1989. Dr. Altman holds Michigan license 4301056490.

Dr. Altman's primary practice is Midwest Center for Dermatology & Pathology, at 11900 E 12 Mile Rd, Warren, MI 48093 in Macomb County. The practice phone is (586) 286-0112.

Dr. Altman's primary practice is Midwest Center for Dermatology & Pathology in Warren, Michigan. Dr. Altman is also affiliated with Henry Ford Warren Hospital. The medical group on file is Midwest Dermatology. Dmand AI also links Dr. Altman to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Altman practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Altman's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Altman is board certified in dermatology by the American Board of Dermatology. Dr. Altman is licensed in Michigan.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Altman treats.

CMS data shows 7,237 Medicare services from Dr. Altman across 28 procedure codes in 2024, for 1,029 Medicare patients. Medicare paid $308,943 for them. Every service was in an office.

CMS counts 1,029 Medicare patients who saw Dr. Altman in 2024. The largest group is 65 to 74, with 453 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Altman's median patient age at 66, with 52% women.

In 2024, Dr. Altman wrote 2,650 Medicare Part D claims for 935 patients. 88% of them were for generic drugs. CMS names the drug for 2,472 of them, across 34 drugs with 11 or more claims each, at $1,028,509 in total drug cost. In 2023, CMS named 2,570 claims across 37 drugs.

Dr. Altman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Altman as offering telehealth. CMS counts 2,312 procedures of removal of skin lesions by Dr. Altman, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Altman, published from 2017 to 2021. The most frequent topics are Skin Neoplasms, Dendritic Cells and Fibroma. Dr. Altman has published most often in JAAD Case Rep. Dr. Altman's most frequent co-authors are David Paul Fivenson, MD, Paul M. Graham, DO and Jeffrey Albert Kushner, DO.

CMS Open Payments shows 3,571 general payments to Dr. Altman from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. Celgene Corporation paid the most, $674,950.

Dmand AI lists 3 awards for Dr. Altman.

Dr. Altman graduated from University Of Michigan Medical School in 1989. Dr. Altman is a member of AAD.

Dr. Altman is in network with 10 carriers, including Aetna, Health Alliance Plan and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.